ENT Devices Market To Observe Ascendant Growth By Rising Prevalence of ENT Conditions Between 2019-2023 - Reuters


ENT Devices Market To Observe Ascendant Growth By Rising Prevalence of ENT Conditions Between 2019-2023

ENT Devices Market To Observe Ascendant Growth By Rising Prevalence of ENT Conditions Between 2019-2023

Wed May 8, 2019 - 10:00am UTC

Market Research Future (MRFR) reports that ENT Devices Market will exhibit a compound annual growth rate of 6.2% during the forecast period (2018-2023). ENT Devices Market Research Report: By Product (Diagnostic (Endoscopes, Hearing Screening) & Surgical (Powered Surgical, Balloon Sinus Dilation, & others))), End User.

Pune, Maharashtra – May 8, 2019

ENT conditions are common across the globe. Some of the common ENT conditions include nasal polyps, hearing loss, muscle tension dysphonia, sinusitis and vocal fold paralysis. Many of the ENT conditions require the patient to use ENT device for treatment or assistance. Improving reimbursement policies in healthcare in both advanced and developing countries is having positive influence on the global ENT devices market. Other factors that are influencing the market include rising geriatric population, growing prevalence of chronic sinusitis, arrival of minimally invasive ENT procedures and increased cosmetic ENT procedures.

Get Free Sample @ https://www.marketresearchfuture.com/sample_request/7197

ENT Devices Market – Competitive Analysis

Companies covered in MRFR’s study include

Cochlear Limited
Johnson & Johnson Services, Inc.
Medtronic PLC
Rion Co. Ltd
Smith & Nephew PLC
Starkey Laboratories Inc.
Widex A/S
Atos Medical AB
Stryker Corporation
Hoya Corporation
Olympus Corporation
Sonova Holding AG
Siemens Healthcare
Karl Storz Gmbh & Co. Kg
William Demant Holding A/S

ENT Devices Market – Segmental Overview

MRFR’s report covers a detailed segmental analysis of the Global ENT Devices Market on basis of end user, product and region.

By end user, the market has been segmented into ambulatory settings, research and academic institutes, hospitals, home care settings, ENT clinics, and others.

Based on product, the market has been segmented into surgical devices, hearing implants, image-guided surgery systems, diagnostic devices, Co2 lasers and hearing aids. The diagnostic devices segment covers hearing screening devices and endoscopes (flexible endoscopes and rigid endoscopes). Types of flexible endoscopes considered for the study are nasopharyngoscopes, laryngoscopes, rhinoscopes and pharyngoscopes. Types of rigid endoscope segment considered for the study are sinuscopes and otoscopes. The surgical devices segment covers radiofrequency (RF) handpieces, balloon sinus dilation devices, ear tubes, powered surgical instruments, voice prosthesis devices, handheld instruments (otology instruments, laryngeal instruments, head and neck surgery instruments, rhinology instruments, and others), and ENT supplies (nasal stents, splint, and packing material).

Presence of a large Number of Market Participant Continues to Favor the North America Market

MRFR’s study covers the global ENT Devices Market across Europe, Asia Pacific (APAC), South America, North America and the Middle East & Africa (MEA). North America and South America collectively account for the largest market share in terms of revenue. Between the two, North America holds the larger share. Several ENT device vendors operate in the US and Canada. The North America ENT devices market is characterised by a number of market players. The competition in the region’s market has heightened in recent years, making it more dynamic. In recent years, incidence of hearing loss has increased in the region partly owing to the rising geriatric population. In 2017, The Hearing Journal released a data, which revealed that close to 44 Mn Americans over the age of 20 are likely to incur hearing loss by 2020.

The Europe ENT devices market is also expected to witness a healthy growth during the forecast period. In terms of revenue, Europe held the second spot in 2017. Technologically advanced countries coupled with the strong R&D pipeline in the ENT devices industry supports the market growth in Europe.

Asia Pacific is viewed as an emerging ENT Devices Market. In fact, the market in APAC is projected to exhibit a highest growth over the next couple of years. Rising healthcare expenditure and increased efforts to deliver affordable care are among the key factors that are propelling the market forward. As per the data released by Australian Institute of Health and Welfare, the Australia spent close to USD 181 Bn on healthcare between 2016 and 2017.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Info:
Name: Market Research Future
Email: Send Email
Organization: Market Research Future
Address: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar Pune – 411028 Maharashtra, India
Phone: +1 646 845 9312
Website: https://www.marketresearchfuture.com/reports/ent-devices-market-7197

This content is not produced by Reuters Editorial News. It is produced by VC NewsNetwork. For content enquiry, please reach us at

Latest News >

Kenanga Investors announces launch of unicorn-focused fund

The fund will feed into the target fund Ericsenz-K2 Global Unicorn Fund.

08:26am UTC

Indonesian fintech firm Achiko to list on SIX Swiss exchange

The company oversees Mimopay which caters to clients in underbanked countries.

06:37am UTC

Digital real estate platform Rever receives US$4M funding from VinaCapital Ventures

The funding comes as a strategic investment for VinaCapital which is a long-time real estate investor and developer

11:07am UTC

Indonesia’s branded apparel-maker Golden Flower aims for IDX listing

The branded apparel manufacturer plans to raise up to US$3.1 million from its initial offering.

08:35am UTC